Last Updated: June 12, 2026

ZIPRASIDONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ziprasidone, and what generic alternatives are available?

Ziprasidone is a drug marketed by Apotex, Aurobindo Pharma, Chartwell Rx, Dr Reddys Labs Inc, Lupin Pharms, Macleods Pharms Ltd, Mylan, Sandoz Inc, Zydus Lifesciences, Gland, MSN, and Steriscience. and is included in twelve NDAs.

The generic ingredient in ZIPRASIDONE is ziprasidone mesylate. There are twenty-three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ziprasidone mesylate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ziprasidone

A generic version of ZIPRASIDONE was approved as ziprasidone mesylate by GLAND on December 26th, 2019.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for ZIPRASIDONE?
  • What are the global sales for ZIPRASIDONE?
  • What is Average Wholesale Price for ZIPRASIDONE?
Summary for ZIPRASIDONE
US Patents:0
Applicants:12
NDAs:12
Drug Prices: Drug price information for ZIPRASIDONE
What excipients (inactive ingredients) are in ZIPRASIDONE?ZIPRASIDONE excipients list
DailyMed Link:ZIPRASIDONE at DailyMed
Drug patent expirations by year for ZIPRASIDONE
Drug Prices for ZIPRASIDONE

See drug prices for ZIPRASIDONE

Drug Sales Revenue Trends for ZIPRASIDONE

See drug sales revenues for ZIPRASIDONE

US Patents and Regulatory Information for ZIPRASIDONE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077562-004 Jun 1, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mylan ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 202395-004 Oct 10, 2013 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Lifesciences ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 208988-001 Aug 22, 2017 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sandoz Inc ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077562-001 Jun 1, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Apotex ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077561-001 Mar 2, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lupin Pharms ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077560-002 Mar 2, 2012 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Macleods Pharms Ltd ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 204375-004 Feb 17, 2017 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links